Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bullock

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The Cochrane Database of Systematic Reviews|May 24, 2021
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementiaEmma L Cunningham, Stephen A Todd, Peter Passmore, et al.
Current Medical Research and Opinion|January 6, 2006
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathologyJacques Touchon, Howard Bergman, Roger Bullock, et al.
International Journal of Geriatric Psychiatry|April 5, 2012
Cochrane review on 'Statins for the treatment of dementia'Bernadette McGuinness, John O'Hare, David Craig, et al.
Journal of Medical Economics|June 5, 2009
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezilHind T Hatoum, Simu K Thomas, Swu-Jane Lin, et al.
Lancet (London, England)|April 20, 2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialTimo Erkinjuntti, Alexander Kurz, Serge Gauthier, et al.
Age and Ageing|May 27, 2015
Incidence of stroke and seizure in Alzheimer's disease dementiaMichael Cook, Nicole Baker, Stephen Lanes, et al.
Current Medical Research and Opinion|April 1, 2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's diseaseRoger Bullock, Howard Bergman, Jacques Touchon, et al.
Clinical Therapeutics|July 16, 2003
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementiaTimo Erkinjuntti, Alexander Kurz, Gary W Small, et al.
Current Medical Research and Opinion|December 23, 2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitorsSerge Gauthier, Murat Emre, Martin R Farlow, et al.
Journal of Alzheimer'S Disease Reports|June 30, 2021
Potential Virus Involvement in Alzheimer's Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug CombinationNina Lindblom, Lars Lindquist, Jacob Westman, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Cochrane Database of Systematic Reviews|May 24, 2021
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementiaEmma L Cunningham, Stephen A Todd, Peter Passmore, et al.
Current Medical Research and Opinion|January 6, 2006
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathologyJacques Touchon, Howard Bergman, Roger Bullock, et al.
International Journal of Geriatric Psychiatry|April 5, 2012
Cochrane review on 'Statins for the treatment of dementia'Bernadette McGuinness, John O'Hare, David Craig, et al.
Journal of Medical Economics|June 5, 2009
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezilHind T Hatoum, Simu K Thomas, Swu-Jane Lin, et al.
Lancet (London, England)|April 20, 2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialTimo Erkinjuntti, Alexander Kurz, Serge Gauthier, et al.
Age and Ageing|May 27, 2015
Incidence of stroke and seizure in Alzheimer's disease dementiaMichael Cook, Nicole Baker, Stephen Lanes, et al.
Current Medical Research and Opinion|April 1, 2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's diseaseRoger Bullock, Howard Bergman, Jacques Touchon, et al.
Clinical Therapeutics|July 16, 2003
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementiaTimo Erkinjuntti, Alexander Kurz, Gary W Small, et al.
Current Medical Research and Opinion|December 23, 2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitorsSerge Gauthier, Murat Emre, Martin R Farlow, et al.
Journal of Alzheimer'S Disease Reports|June 30, 2021
Potential Virus Involvement in Alzheimer's Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug CombinationNina Lindblom, Lars Lindquist, Jacob Westman, et al.
Pageof 7